Image from Google Jackets

2020-2021 Oncology Nursing Drug Handbook

By: Contributor(s): Publication details: Massachusetts : Jones & Bartlett, 2020ISBN:
  • 1284171329
  • 9781284171327
Subject(s):
Contents:
Introduction to chemotherapy drugs; Cytoprotective agents; Molecular targeted therapy; Immunologic targeted therapy; Chemobiotherapy for noncancer diseases; Pain; Nausea and vomiting; Anorexia and cachexia; Anxiety and depression; Managing tumor-related skeltal events and hypercalcemia; Infection; Constipation; Diarrhea; Appendix 1 - Occupational exposure to hazardous drugs; Appendix 2 - Common terminology criteria for adverse events (CTCAE)
Summary: Completely revised and updated, the 2020-2021 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for drugs recently approved by the FDA.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Home library Class number Status Date due Barcode
Book David Adams Library (Royal Marsden) Shelves QZ267 WIL (Browse shelf(Opens below)) Pending reservation 0000007692

Introduction to chemotherapy drugs; Cytoprotective agents; Molecular targeted therapy; Immunologic targeted therapy; Chemobiotherapy for noncancer diseases; Pain; Nausea and vomiting; Anorexia and cachexia; Anxiety and depression; Managing tumor-related skeltal events and hypercalcemia; Infection; Constipation; Diarrhea; Appendix 1 - Occupational exposure to hazardous drugs; Appendix 2 - Common terminology criteria for adverse events (CTCAE)

Completely revised and updated, the 2020-2021 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for drugs recently approved by the FDA.

There are no comments on this title.

to post a comment.
London Health Libraries Koha Consortium privacy notice